Decrease in Temperature as a Pagtonomic Sign by Scorpion Sting

Sponsor
Mexican Red Cross (Other)
Overall Status
Completed
CT.gov ID
NCT03622125
Collaborator
Instituto Bioclon S.A. de C.V. (Industry)
184
1
2.3
78.9

Study Details

Study Description

Brief Summary

The scorpion sting is a medical disease, for the signs and symptoms presented; Sometimes patients do not know the animal that causes these symptoms; the bibliography marks the decrease in temperature as a sign to be presented.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Vital signs

Detailed Description

The scorpion sting is a medical emergency where 184 patients from the state of Guanajuato were divided into 2 groups according to the type of antivenom administered, the dose of antivenom were at the discretion of the attending physician, Birmex (n = 117) and Alacramyn (n = 67) for the temperature record of the site of sting and other vital signs, this to compare it with the bibliography as a pathognomonic sign.

Study Design

Study Type:
Observational
Actual Enrollment :
184 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Decrease in Temperature by Scorpion Sting: a Pagtonomic Sign
Actual Study Start Date :
May 20, 2017
Actual Primary Completion Date :
Jun 15, 2017
Actual Study Completion Date :
Jul 30, 2017

Arms and Interventions

Arm Intervention/Treatment
1

Patients who apply anti-scorpion venom serum Birmex at the discretion of the attending physician were given vital signs.

Diagnostic Test: Vital signs
Axillary temperature sampling, at the site of the scorpion sting and the contralateral site with infrared thermometer, and heart rate, respiratory rate and blood pressure on admission, 30 minutes after applying the vial and the medical discharge

2

Patients who apply anti-scorpion venom serum Alacramyn at the discretion of the attending physician were given vital signs.

Diagnostic Test: Vital signs
Axillary temperature sampling, at the site of the scorpion sting and the contralateral site with infrared thermometer, and heart rate, respiratory rate and blood pressure on admission, 30 minutes after applying the vial and the medical discharge

Outcome Measures

Primary Outcome Measures

  1. Temperature change [0, 30 and 120 minutes]

    Temperature at the sting site, contralateral site and axillary in degrees celcius

Secondary Outcome Measures

  1. Blood preasure [0, 30 and 120 minutes]

    Systolic and diastolic in mmHg

  2. Heart rate [0, 30 and 120 minutes]

    Beats per minute

  3. Respiratory rate [0, 30 and 120 minutes]

    Breaths per minute

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Scorpion sting

  • All sex

  • 3 - 90 ages

Exclusion Criteria:
  • Application of ice at the sting site

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cruz Roja Mexicana, Delegación León León Guanajuato Mexico 37179

Sponsors and Collaborators

  • Mexican Red Cross
  • Instituto Bioclon S.A. de C.V.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Josue Saul Almaraz Lira, Principal Investigator, Mexican Red Cross
ClinicalTrials.gov Identifier:
NCT03622125
Other Study ID Numbers:
  • CRM-Alacranes-2017
First Posted:
Aug 9, 2018
Last Update Posted:
Aug 15, 2019
Last Verified:
Aug 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2019